News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
10 Results
Section
Business (6)
Drug Development (3)
Job Trends (1)
News (10)
Tag
Alliances (1)
Clinical research (3)
Earnings (2)
Job creations (1)
People (3)
Phase 2 (2)
Phase 3 (1)
Date
2023 (1)
2017 (2)
2014 (2)
2013 (1)
2010 (1)
10 Results for "novartis.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
NeoGenomics Expands Board of Directors with Appointments of Three Independent Directors
NeoGenomics, Inc. today announced the appointment of Elizabeth Floegel, Neil Gunn, and Tony Zook to its Board of Directors.
June 29, 2023
·
5 min read
Business
CTI BioPharma Appoints David R. Parkinson, M.D., Leader In Oncology Clinical Development, To Board Of Directors And Announces Board Member Resignations
June 6, 2017
·
4 min read
Business
Cell Therapeutics, Inc. Reaches Agreement To Reacquire Rights To Two Anti-Cancer Compounds
January 13, 2014
·
7 min read
Drug Development
Cell Therapeutics, Inc. Announces Data Safety and Monitoring Board Recommendation to Continue the GOG-0212 Phase 3 Clinical Trial of OPAXIOTM as Maintenance Therapy in Ovarian Cancer
January 31, 2013
·
6 min read
Business
Former Scientific Director at Genomics Institute of the Novartis Research Foundation Named President of Cell Therapeutics Europe
October 6, 2008
·
4 min read
Business
ProQR Announces Results for the Third Quarter of 2017
Runway into the second half of 2019: cash of €39.7 million at end of Q3.
November 20, 2017
·
22 min read
Drug Development
Cell Therapeutics, Inc.: OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer
October 1, 2009
·
6 min read
Drug Development
Cell Therapeutics, Inc.: OPAXIO Phase II Study in Patients with Advanced Esophageal Cancer Results to be Presented at the American Society of Clinical Oncology 2010 Annual Meeting
May 24, 2010
·
5 min read
Business
Cell Therapeutics, Inc. Reports First Quarter 2014 Financial Results
April 30, 2014
·
11 min read
Job Trends
Cell Therapeutics, Inc. (JOBS) Focuses on Late-Stage Drug Approvals and Commercialization and Cuts Operating Costs: to Close Bresso Research Center
February 27, 2009
·
6 min read